Related by context. All words. (Click for frequent words.) 64 EP# [003] 63 liposomal formulation 61 generation purine nucleoside 61 GV# [001] 60 PG# [004] 60 non nucleoside inhibitor 60 DB# [003] 59 receptor tyrosine kinase inhibitor 59 PEGylated interferon 58 EP# [005] 58 oral prodrug 58 TRC# 58 intranasal formulation 58 AKT inhibitor 58 NET# [002] 58 NRTI resistance 58 E# E# [003] 58 selective orally bioavailable 57 nucleoside reverse transcriptase inhibitor 57 TG# [004] 57 AT# [002] 57 paclitaxel Taxol 57 non nucleoside 57 boosted protease inhibitor 57 immunomodulatory therapy 57 Alferon N 57 metaglidasen 57 PI3K inhibitor 57 nucleoside analog 57 mertansine 57 Gleevec resistant 57 TAT# 57 vidofludimus 57 PEGylated Fab fragment 57 fosbretabulin 57 Ultratrace 56 BrachySil 56 immunotherapeutic agent 56 SG# [002] 56 PRO# [003] 56 PEG IFN 56 M#V 56 Hsp# Inhibitor 56 TG# [001] 56 TH# [003] 56 FT# [001] 56 Chemokine Receptor 56 protease inhibitor PI 56 targeted radiotherapeutic 56 HGS# 56 cetuximab Erbitux ® 56 tumor xenograft models 56 ribavirin Copegus ® 56 Darunavir 56 5 HT3 antagonist 56 CCR5 antagonist 56 Phase Ib study 56 ceftazidime 56 PN# [001] 56 GA# [003] 56 aldehyde dehydrogenase ALDH2 deficiency 56 Apoptone 56 mapatumumab 56 XL# XL# 56 small molecule Hedgehog 56 volociximab 56 melphalan prednisone 56 AX# [001] 56 androgen receptor antagonist 56 anticancer compound 55 Panzem R NCD 55 Phase #b/#a clinical 55 paclitaxel poliglumex 55 Traficet EN 55 Albuferon TM 55 Deadlinepix 55 Xanafide 55 Pharmacokinetics PK 55 Receptor Antagonists 55 selectively binds 55 Cloretazine 55 ONX 55 Alocrest 55 miconazole Lauriad ® 55 SCH # 55 amrubicin 55 drug conjugate 55 GW# [003] 55 FOLFOX6 55 Annamycin 55 somatostatin analogue 55 CDK inhibitor 55 KX2 55 dopamine partial agonist 55 orally bioavailable 55 TG# [003] 55 CRLX# 55 DermaVir 55 NOD SCID mice 55 metastatic malignant 55 selective agonist 55 subcutaneous formulation 55 PDE4 inhibitor 55 gemcitabine Gemzar 55 proteasome inhibitor 55 Blinatumomab 55 investigational integrase inhibitor 55 Archexin 55 ADL# 55 gemcitabine carboplatin 54 radiolabeled monoclonal antibody 54 Phase 1a clinical 54 LX# [003] 54 #G XFP 54 randomized controlled Phase 54 CYT# potent vascular disrupting 54 TRX# 54 CLORETAZINE TM VNP#M 54 Oral Spray 54 vinca alkaloid 54 virus AAV 54 vapreotide acetate 54 humanized anti 54 selective antagonist 54 intravesical instillation 54 CD# monoclonal antibody 54 Liposomal 54 DermaVir Patch 54 Zoraxel TM 54 Factor VIIa 54 ADP receptor antagonist 54 pegfilgrastim 54 kinase inhibitor 54 Epirubicin 54 Phase 2b Trial 54 novel oral anticoagulant 54 PSN# [002] 54 ritonavir boosted 54 refractory prostate cancer 54 AIR# [001] 54 oral proteasome inhibitor 54 generation FBPase inhibitor 54 EASy 54 recombinant adeno associated 54 RhuDex ® 54 targeted antifolate 54 Phase IIb clinical trials 54 TLK# 54 Panzem NCD 54 Phase 2a Clinical Trial 54 AS# amonafide L malate 54 CD# antibodies 54 BrachySil ™ 54 Phase Ib clinical 54 OMNARIS Nasal Spray 54 ritonavir boosted protease inhibitor 54 Medoxomil 54 CCR5 inhibitor 54 Phase Ib II 53 HGS ETR1 53 orally inhaled 53 oral nucleoside analogue 53 Bevirimat 53 Orally administered 53 PHX# 53 sublingual formulation 53 vinorelbine tartrate 53 phase IIb trial 53 XL# [003] 53 Hormone Refractory Prostate Cancer 53 Levoleucovorin 53 Aurora kinase inhibitor 53 TP# [002] 53 tartrate Inhalation Solution 53 Module RTM 53 DEB# 53 KB# [004] 53 dose cohort 53 cutaneous T 53 reslizumab 53 favorable pharmacokinetic profile 53 topical gel formulation 53 polymerase inhibitors 53 preclinical efficacy 53 novel emulsion formulation 53 MF# [002] 53 PARI Pharma GmbH 53 BENLYSTA ® 53 ORENCIA ® 53 BrachySil TM 53 PE# [004] 53 IgG1 antibody 53 tumor vascular disrupting 53 Bruton tyrosine kinase Btk 53 ChronVac C R 53 MoxDuo 53 Daclizumab 53 Bortezomib 53 alvespimycin 53 orally dosed 53 Intravesical 53 peptide antigens 53 Sapacitabine 53 prokinetic agent 53 paclitaxel Taxol ® 53 Degarelix 53 IMC A# 53 DG# [003] 53 CBLC# 53 torezolid 53 p# inhibitor 53 Cyanokit R 53 Methylnaltrexone 53 immunotoxin 53 Revimmune 53 Nebulizer System 53 Dapagliflozin 53 Forodesine 53 Investigational eFlow Nebulizer System 53 RP# [002] 53 AZILECT R 53 PEGPH# 53 Investigational Oral 53 OvaRex R 53 Phase IIb trials 53 EOquin 53 ND# [002] 53 temsirolimus Torisel ® 53 PDX pralatrexate 52 EndoTAG 52 busulfan 52 AFREZZA TM 52 ALVESCO ® 52 intravesical 52 MKC# MKC# PP 52 visilizumab 52 ALGRX 52 TLR8 agonist 52 KNS # 52 BC# [003] 52 PI3K/Akt pathway inhibitor 52 MU# [002] 52 solithromycin 52 LX# LX# 52 Xyfid TM 52 NS# [003] 52 fallopian tube cancers 52 SIR Spheres 52 etoposide 52 rusalatide acetate 52 Tasimelteon 52 investigational immunotherapy 52 PRX# 52 peripherally acting 52 prodrugs 52 Enkephalin 52 Silodosin 52 Antibody Drug Conjugate 52 AMCC QT# 52 BIO SET 52 potent cytotoxic 52 ZACTIMA 52 bevacizumab Avastin R 52 recurrent glioblastoma 52 Imatinib mesylate 52 Dyloject TM 52 molecular imaging radiopharmaceutical 52 ongoing Phase 1b 52 HuMax CD4 52 ME# [002] 52 Initiate Clinical Trial 52 sunitinib malate 52 Elotuzumab 52 DNA intercalator 52 tenofovir disoproxil fumarate Viread 52 nanopharmaceutical 52 intravenous dosing 52 replicon 52 NH# [002] 52 TKB# 52 Phase 1b trial 52 inhalation powder 52 MGN# 52 pharmacokinetic PK study 52 ALVESCO R 52 VELCADE melphalan 52 HA# 52 allogeneic cell 52 humanized antibody 52 eribulin mesylate 52 bortezomib Velcade ® 52 biliary tract cancer 52 mAb 52 fluticasone furoate 52 XP# XP# 52 OSMOPREP 52 Cloretazine VNP#M 52 PAM4 52 Melphalan 52 HYLENEX recombinant 52 Loxapine 52 ELISA kit 52 TM# [001] 52 MEK inhibitors 52 UD5 52 XTEN 52 VAPRISOL 52 ATL# [001] 52 multigene expression test 52 MKC# 52 CX# CX# [001] 52 PF# [002] 52 inhalation aerosol 52 Vaprisol 52 farletuzumab 52 essential thrombocythemia ET 52 Quinamed 52 TELINTRA 52 Multistream 52 mesalazine 52 RNA amplification 52 concurrent chemoradiation 51 Phase 2a trial 51 HBV vaccine 51 GLP1 agonist 51 HuMax 51 Immunoassay System 51 fluoropyrimidine 51 monoclonal antibody mAb 51 novel synthetic peptide 51 amikacin 51 Pralatrexate 51 trodusquemine 51 Cimzia TM 51 liposomal doxorubicin 51 Soliris eculizumab 51 Insulin PH# 51 Trobalt 51 salmeterol fluticasone 51 ESBA# 51 nucleoside polymerase inhibitor 51 antisense inhibitor 51 Receptor Antagonist 51 Linear Array 51 vascular disrupting agents 51 D#A [002] 51 triple quadrupole mass spectrometer 51 PT# Pro 51 SYN# 51 DU# [002] 51 Tyrosine Kinase Inhibitor 51 Dynavax HBV vaccine 51 VersaFilm 51 immune modulating 51 NRTI 51 proteasome inhibitor bortezomib 51 SELZENTRY 51 Cetuximab Erbitux 51 Resten NG 51 triphendiol 51 investigational protease inhibitor 51 ZOLINZA 51 Transdermal System 51 Successfully Demonstrated 51 histamine dihydrochloride 51 oral rivaroxaban 51 PROVENGE ® 51 AEGR 51 RH1 51 brand ciclesonide HFA 51 adenoviral vectors 51 HDACi 51 X#A 51 Darusentan 51 regorafenib 51 QbG# 51 granisetron formulated 51 Phase 2a 51 BNC# 51 proprietary polysaccharide 51 mu opioid receptor antagonist 51 lamivudine zidovudine 51 novel nucleoside analog 51 V#E 51 beta2 agonist 51 Capesaris 51 auristatin 51 pomalidomide 51 PC Detect SM 51 Aeroquin 51 vemurafenib 51 aerosol formulation 51 gemtuzumab ozogamicin 51 SFP transceivers 51 Infusion System 51 XL# XL# XL# 51 WP# [002] 51 Perforomist ™ Inhalation Solution 51 XR#M# 51 inhaled formulation 51 depsipeptide 51 EOquin TM 51 HER2 antibody 51 RJ# ports 51 subcutaneously administered 51 TO AVOID PREGNANCY WHILE 51 Doxorubicin 51 IN.PACT Falcon 51 octreotide acetate 51 AV2 51 Siemens Simatic 51 PD# [002] 51 CRp 51 Myocardial Perfusion Imaging 51 TAFA# 51 zileuton 51 VDSLPlus TM 51 HCl Injection 51 intratumoral injection 51 Nucleic Acid Test 51 C#A [002] 51 Epoprostenol 51 Aerosurf 50 ARIKACE ™ 50 platelet inhibitor 50 Paromomycin 50 opioid induced bowel dysfunction 50 SO DIMM 50 Mg Usa 50 NNRTI resistant virus 50 selective adenosine 50 #/#Base-T 50 apomorphine hydrochloride 50 targeted tyrosine kinase 50 cystic fibrosis bronchiectasis 50 nasal spray formulation 50 investigational antiplatelet 50 acting neuraminidase inhibitor 50 FVIIa 50 XC# [003] 50 refractory NSCLC 50 MGd 50 Inhaled AAT 50 JUVISTA R Human 50 Smart Array 50 PV# [003] 50 STV# 50 IV bolus formulation 50 Zybrestat 50 PC3 50 Meets Primary Endpoint 50 Ceflatonin R 50 Afinitor everolimus 50 Files Investigational 50 SO DIMMs 50 IIIc 50 elvitegravir 50 Bicifadine 50 triciribine phosphate monohydrate 50 Virulizin ® 50 EGFR HER2 50 Inhalation Solution 50 Ganciclovir 50 dacetuzumab 50 Oral NKTR 50 CytoFabTM 50 developing Bicifadine serotonin 50 UGT#A# 50 MB# MB# 50 CD3 monoclonal antibody 50 Pilocarpine 50 NS4A 50 ISENTRESS 50 tumor lysate 50 Transdermal Patch 50 tumor necrosis 50 Prothrombin 50 olmesartan medoxomil hydrochlorothiazide 50 ancrod 50 clonidine hydrochloride 50 UD7 50 Aplidin R 50 CCR5 tropic HIV 50 naltrexone SR 50 xenograft models 50 Panzem ® 50 BN# [002] 50 MoxDuo ® 50 Model #A 50 Keppra XR 50 CAPHOSOL R 50 multicenter Phase II 50 Dacogen decitabine 50 SD SDIO MMC 50 Hedgehog Pathway Inhibitor 50 TPI ASM8 50 bortezomib Velcade R 50 XmAb 50 Benephit 50 SODIMM 50 Tumor Response 50 IPLEX 50 6mg 50 Velcade bortezomib 50 NanoTab 50 Preclinical studies suggest 50 T1c 50 inhaled AAT 50 ixabepilone 50 doxorubicin docetaxel 50 PHASE III 50 nanomolar 50 plasmid encoding 50 CellSearch ™ 50 GLP1 INT TM 50 #.#b WLAN 50 raltegravir 50 Celgosivir 50 peptide conjugated 50 OXi# 50 EpiCept NP 1 50 Cefazolin 50 COBAS R 50 Dual Opioid 50 intraperitoneally 50 AV# [001] 50 ganetespib 50 porcine derived 50 echinocandin 50 inhaled corticosteroid ICS 50 GAMMAGARD 50 lipopeptide 50 effector function 50 TKI therapy 50 anti leukemic 50 DDP# 50 Pulse Width Modulation PWM 50 Cypress WirelessUSB 50 tipranavir 50 nebulized formoterol fumarate 50 subcutaneous dosing 50 alfa interferon 50 Oral Insulin 50 small molecule chemotherapeutic 50 Cimzia ® certolizumab pegol 50 SN# [001] 50 somatostatin analogues 50 samalizumab 50 GALNS 50 lysate 50 Qdot 50 Bluetooth transceiver 50 VBLOC TM 50 tanespimycin 50 Cethrin R 50 Fenretinide 50 pen injector 50 Canvaxin TM 50 BeneFIX 50 tumor antigen 50 potent CYP#A# inhibitors 50 Cloretazine R 49 NNRTIs 49 Tapentadol 49 MiniArc Precise 49 adenosine injection 49 recombinant interferon 49 subcutaneous Herceptin 49 pharmacodynamic properties 49 SDIO interface 49 vivo potency 49 MicroThermX Microwave Ablation System 49 Ethernet Extender 49 adipogenic 49 PrandiMet TM 49 agonist LABA 49 Zemiva ™ 49 pharmacokinetic PK 49 proton pump inhibitor PPI 49 8 pin MSOP 49 omega interferon 49 ZX# [001] 49 irinotecan oxaliplatin 49 CX# [004] 49 Micromet BiTE 49 ATPace TM 49 NUVIGIL ® 49 CRMD# 49 Cloretazine R VNP#M 49 antifolates 49 tumor specific antigen 49 transfection reagent 49 BRIM2 49 ART# 49 Ceplene TM 49 Angiolix 49 Enzastaurin 49 topical formulation 49 XD# [001] 49 Phase 2b study 49 antiretroviral regimen 49 LEUKINE 49 VP# [003] 49 OMNARIS AQ 49 phosphorothioate 49 IIIa inhibitor 49 ACUROX 49 zinc cysteine 49 Initiates Phase II 49 ProSafe RS 49 KRN# 49 X4 tropic 49 Exenatide Byetta 49 Serial Ports 49 Vascular Disrupting Agent 49 Lauriad 49 DirectFET R 49 NXC 49 Butterfly Valve 49 #/#BaseT Ethernet 49 crizotinib PF # 49 chemotherapeutic drug 49 Microwave Ablation System 49 Septin9 49 polycythemia vera PV 49 IMC #B 49 NRTIs 49 MIC#/# 49 Phase IIb Clinical Trial 49 CCR5 antagonists 49 DUROS 49 nucleoside reverse transcriptase inhibitors 49 ADSL2 + Modem Router 49 OptoCooler HV# 49 E StaX 49 Demonstrates Potential 49 PN# [003] 49 Zysolin TM 49 liposome formulation 49 PrevOnco 49 HCV replicon 49 oncolytic adenovirus 49 Zolpimist ™ 49 ACUROX ® 49 XOMA 3AB 49 eZdsp 49 XP# [003] 49 GX# [001] 49 HepaGam B 49 ALC# 49 murine models 49 convenient dosing regimens 49 gonadotropin releasing hormone GnRH 49 ALN HPN 49 WiMAX CPEs 49 DURECT proprietary 49 selective A2A adenosine receptor 49 iSONEP 49 Packet Optical Platform 49 Alvesco R 49 opioid receptor antagonist 49 QuadraSphere 49 efavirenz EFV 49 ImmuKnow R 49 CHO K1 49 PXD# 49 solifenacin succinate 49 AAV vectors 49 AMEVIVE 49 chemokine receptor 49 bispecific antibody 49 parenterally administered 49 small molecule tyrosine 49 MT#C 49 Cleviprex TM clevidipine 49 DermaPrep 49 aromatase inhibitor AI 49 arginine vasopressin AVP 49 uses eFlow Technology 49 HCl capsules 49 procainamide 49 miRview TM mets 49 Investigational eFlow 49 miRview ™ squamous 49 Galantamine 49 AX# [002] 49 prostone 49 Vinorelbine 49 kinase profiling 49 muco adhesive technology 49 insulin aspart 49 sargramostim 49 VISICOL R 49 Dynabeads 49 trastuzumab Herceptin ® 49 bioabsorbable polymer 49 V# V# [001] 49 VivaGel TM 49 Glucophage R 49 Aptocine 49 NAVISTAR R 49 NEBS certified 49 NSCLC tumors 49 connectorized 49 Cytolin R 49 MET inhibitor 49 trastuzumab emtansine T DM1 49 S/GSK# 49 Cylene 49 nab docetaxel 49 catheter occlusion 49 blinded randomized placebo controlled 49 kinase inhibition 49 buccal spray 49 receptor agonists 49 Atmel AT#SAM# 49 array AESA 49 Sentiris 49 Darinaparsin 49 muscarinic antagonist 49 CX# [002] 49 allergic airway inflammation 49 rxRNA ™ compounds 49 ISL#E [001] 48 anti tubercular 48 OvaRex MAb 48 M1 muscarinic 48 partial remissions 48 chain antibody fragment 48 GL# [003] 48 receptor agonist 48 GMX# 48 abacavir Ziagen 48 HuCAL PLATINUM 48 miRview mets 48 Urocidin 48 Maleate 48 pharmacodynamic endpoints 48 Achieves Primary Endpoint 48 small molecule agonists 48 Morpholino 48 Dural Sealant 48 Anticalins R 48 fludarabine phosphate 48 BiTE 48 systemic immunosuppressive drugs 48 metastatic castration resistant 48 patented Bioral 48 tiapamil 48 Zensana TM 48 PE# [001] 48 XC Cube 48 NP# [002] 48 hPTH #-# 48 Hedgehog pathway inhibitor 48 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 48 successfully commercialize Iluvien 48 DACH platinum 48 Dural Regeneration Matrix 48 EGFR antibodies 48 DeviceMaster 48 AM3 Motherboard 48 combretastatin A4 phosphate CA4P 48 pioglitazone HCl 48 EXPAREL TM 48 atazanavir ritonavir 48 Japanese Encephalitis vaccine 48 tramiprosate Alzhemed TM 48 TWTAs 48 Technology Demonstrator 48 BGC# 48 Heatsink Review 48 MAb 48 antibody arrays 48 occlusion PAO 48 EML4 ALK 48 #TX [002] 48 T#/T# 48 siRNA therapeutic 48 oral transmucosal 48 Upgrade Kit 48 nizatidine 48 genotypic resistance 48 Dabigatran etexilate 48 Immunotherapeutic 48 Enhanze Technology 48 anti phosphatidylserine 48 VeriStrat 48 AMD# [003] 48 LAB CGRP 48 anti emetic therapy 48 amifampridine phosphate 48 CTA# 48 Novel Antibody 48 CANCIDAS 48 QT QTc 48 Prefilled Syringe 48 ULN 48 SSAO 48 AdvancedMC module 48 Phase IIa Clinical Trial 48 CMS# 48 #Y ibritumomab tiuxetan 48 Phase 2a clinical 48 poly ICLC 48 XG# [001] 48 Maraviroc 48 Eternus 48 TPV r 48 HBsAg 48 microplate format 48 VAX# 48 PI3K inhibitors 48 Thermo Scientific LTQ Orbitrap 48 XFP transceivers 48 micro ATX motherboard 48 ER4 48 Initiate Phase 48 Beam Forming 48 preclinical xenograft models 48 RTP #i 48 electro-optical/infrared 48 BelaSigna 48 V#L 48 VITROS ® 48 CopperTen 48 DCCR 48 Ecallantide 48 cdma# 1X 48 chemo immunotherapy 48 G#A [001] 48 LNP formulations 48 nucleoside 48 NeoLipid R 48 #.#af compliant 48 ConnectCore Wi i.MX# 48 including eniluracil ADH 48 biodegradable implant 48 Surgical Mesh 48 OCZ DDR3 48 CyPath R 48 transthyretin TTR mediated amyloidosis 48 tolevamer 48 NEXTERONE 48 chip debugging emulator 48 ATD Gel 48 urethral bulking agent 48 pharmacodynamics PD 48 ® natalizumab 48 iChem VELOCITY 48 basal insulin 48 interleukin IL 48 Anticalins ® 48 OmniWave 48 enfuvirtide Fuzeon 48 brentuximab vedotin SGN 48 Pennsaid R 48 Interferon beta 48 retaspimycin 48 ADAGIO study 48 either acutely decompensated 48 PowerPak 48 LG# [002] 48 bolus injection 48 pharmacokinetics PK 48 HTRF 48 CyPath 48 GORE VIABAHN ® 48 pin SOIC package 48 Ultra2 48 IWLAN 48 topoisomerase II inhibitor 48 molecular assays 48 #MB DDR SDRAM 48 Ampligen r 48 Clinical Trial Results 48 MoxDuo R 48 delipidation 48 DP4 48 CorVue ™ 48 E#K# 48 Fibrin Sealant 48 Sitrans 48 Merlin 1C 48 FP# [003] 48 Exelixis XL# 48 qPCR assays 48 monoclonals 48 Atom D# 48 Roaming Client 48 PCI Express SSD 48 Equetro 48 inhibitor PPI 48 CB# [002] 48 Biojector 48 Sufentanil 48 myeloproliferative disorders 48 DE# [001] 48 recombinant tissue plasminogen 48 GEMS TM 48 carcinoid syndrome 48 #HS [001] 48 hyaluronidase enzyme 48 levodopa carbidopa 48 herpes labialis 48 multiplex PCR 48 NADiA 48 initiate Phase 1b 47 Rev Dex 47 USB RS# 47 IX# [002] 47 IB# [002] 47 haematologic 47 throughput mass spectrometry 47 kinase inhibitors 47 Fujitsu XG# 47 BEMA Granisetron 47 SN#P 47 AOZ# 47 synDNA TM 47 novel immunotherapeutic 47 Lucanix 47 ASUS P#P#D 47 SOHO router 47 catheter occlusion CO 47 DNAwithPap TM Test 47 semisynthetic 47 CE Marked 47 Shuttle XPC Barebone 47 oxybutynin gel 47 Chemophase 47 Phase III Pivotal 47 VersaLink 47 Hemodiafiltration 47 subcutaneous implant 47 UWB chipset 47 CWave R 47 Cardica Microcutter XPRESS 47 HDS# 47 TRF# [001] 47 lentiviral vector 47 IFN Beta CTP 47 multiplex assay 47 audio CODEC 47 X# X# X# 47 Hemopurifier ® 47 GB SATA drives 47 Monoclonal antibodies 47 EPSON Stylus 47 antifolate 47 aerosolized KL4 surfactant 47 Protocol Analyzer 47 #G transceivers 47 Abbokinase 47 VBLOC 47 CPC# [002] 47 1mg 2mg 47 immunofluorescence staining 47 NGX# 47 RC# [003] 47 Abbott ARCHITECT 47 dimesylate 47 INTELENCE 47 cellular cytotoxicity 47 absorption enhancer 47 Agilent #B [002] 47 inhaled iloprost 47 IFN alpha 47 milatuzumab 47 Pad Abort 1 47 DualHead 47 TMC# [001] 47 Autologous Thrombin Processing 47 INOmax 47 BUPHENYL R sodium phenylbutyrate 47 acute peripheral arterial 47 Performance Acceleration Module 47 3Com VCX 47 liposome formulations 47 Expresscard 47 orally disintegrating 47 B2A 47 GNSS Receiver 47 Tensilica DPUs 47 Liposomes 47 Targretin capsules 47 dual reuptake inhibitor 47 RNAi compounds 47 Commences Phase 47 ANTEGREN 47 intratumoral 47 C# C# [003] 47 SRT# [003] 47 ADVIA Centaur 47 Rear Transition 47 Multiple Ascending Dose 47 lanreotide 47 PMA# 47 MAbs